Bodhi Tree Biotechnology (BDTB) Common Equity (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported Common Equity of $66213.0 for Q4 2025, down 67.55% year-over-year from $204050.0 in Q4 2024, and down 44.43% quarter-over-quarter from $119161.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) Common Equity (2024 - 2025) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has 2 years of Common Equity data on file, last reported at $66213.0 in Q4 2025.
- Common Equity for Q4 2025 came in at $66213.0, down 67.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $66213.0 (down 67.55% YoY), and the FY2025 annual result was $119161.0, down 55.67% from the prior year.
- Common Equity eased to $66213.0 in Q4 2025 per BDTB's latest filing, from $119161.0 in the prior quarter.
- Over five years, Common Equity peaked at $268827.0 in Q3 2024 and troughed at $66213.0 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,213.00 |
| Sep 30, 2025 | 119,161.00 |
| Jun 30, 2025 | 129,848.00 |
| Mar 31, 2025 | 150,622.00 |
| Dec 31, 2024 | 204,050.00 |
| Sep 30, 2024 | 268,827.00 |